25Serious

Larry Gordon

Ask VT AI

View News Summary

Russia tests nuclear-powered cruise missile, sparking skepticism from experts over its capabilities and risks.
Novartis nears $70 billion acquisition of Avidity Biosciences to expand its RNA therapeutics pipeline for neuromuscular diseases.
Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Russia tests nuclear-powered cruise missile, sparking skepticism from experts over its capabilities and risks.
Novartis nears $70 billion acquisition of Avidity Biosciences to expand its RNA therapeutics pipeline for neuromuscular diseases.
Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Larry Gordon